Bioweg has secured a €16 million Series A funding round to scale its development of bio-based, biodegradable materials as a sustainable alternative to microplastics in various industries.
Information on the Target
Bioweg is an innovative company focused on addressing the global microplastics crisis by developing next-generation, bio-based, and biodegradable materials. The company converts food industry by-products into bacterial cellulose via precision fermentation, refining these materials through green chemistry to create alternatives to fossil-based polymers. Bioweg aims to replace harmful microplastics in various applications with sustainable solutions.
The company has successfully validated its technology at the pilot scale and is now poised to construct its first bacterial cellulose production facility. This ambitious step is supported by a €16 million Series A funding round, aimed at scaling their products for market introduction.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The issue of microplastics has reached epidemic proportions globally, with European countries leading in regulatory responses. Europe has implemented a progressive ban on the use of microplastics, starting with rinse-off cosmetics s
Similar Deals
Axeleo Capital
invested in
Bioweg
in 2023
in a Series A deal
Disclosed details
Transaction Size: $17M